malondialdehyde has been researched along with Fatty Liver, Nonalcoholic in 93 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 69 (74.19) | 24.3611 |
| 2020's | 24 (25.81) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Peng, X; Sun, C; Tang, C; Yang, D; Zheng, L; Zhou, Z; Zou, Y | 1 |
| Ben-Arie, E; Chan, YC; Hong, LZ; Kao, PY; Lee, IT; Lin, WT; Lin, YH; Lu, MC; Yang, MD | 1 |
| Fan, YN; Gao, QH; Guo, YQ; Tao, XJ; Yang, JJ; Zhang, YN | 1 |
| Hu, M; Li, S; Qin, H; Shaukat, H; Song, Z; Zheng, W | 1 |
| Ahmadijoo, P; Alsaikhan, F; Asl, SMKH; Bokov, DO; Far, ZG; Jannat, B; Mahmudiono, T; Mazloom, Z; Rostamizadeh, P | 1 |
| Shu, S; Wang, H; Wang, Q; Xu, Z | 1 |
| Abd El-Monem, AM; Ali, RH; El Agaty, SM; Galal Hamam, G; Lasheen, NN; Lebda, FM | 1 |
| Peng, Y; Wan, L; Yang, R; Zhu, H | 1 |
| Antonello, M; Brosolo, G; Catena, C; Da Porto, A; Donnini, D; Romanin, A; Sechi, LA; Soardo, G; Toritto, P; Vanin, F; Varisco, E | 1 |
| Jiang, H; Jin, Y; Li, B; Li, D; Wang, Z; Xia, H; Zhang, X; Zhu, X | 1 |
| Arya, A; Azarmehr, N; Doustimotlagh, AH; Mansourian, M | 1 |
| Carvajal, S; Casals, E; Casals, G; Fernández-Varo, G; González de la Presa, B; Jiménez, W; Morales-Ruíz, M; Oró, D; Parra, M; Pastor, Ó; Perramón, M; Puntes, V; Ribera, J | 1 |
| Wang, H; Yu, D; Yuan, Y; Zhang, L; Zhang, Y | 1 |
| Ceballos, G; Hidalgo, I; Meaney, E; Nájera, N; Pérez-Durán, J; Valdespino-Vazquez, Y; Villarreal, F | 1 |
| Amirkhizi, F; Asghari, S; Hamedi-Shahraki, S | 1 |
| Jiang, W; Wang, J | 1 |
| Abdel-Latif, RG; El-Deen, RM; Heeba, GH; Khalifa, MMA | 1 |
| Lawrence, L; Majeed, M; Majeed, S; Mundkur, L; Nagabhushanam, K | 1 |
| Cao, P; Du, L; Li, J; Li, Y; Liu, Y; Su, Q; Xu, YJ; Yu, X | 1 |
| Gao, Y; Huang, W; Li, J; Xiao, Q; Zhang, J; Zhang, S; Zhao, J; Zhu, Y | 1 |
| Alavinejad, P; Amani, R; Fathi, M; Haidari, Z | 1 |
| Baldini, F; Khalil, M; Miraglia, N; Putignano, P; Vergani, L; Voci, A | 1 |
| Açıkel Elmas, M; Arbak, S; Atay, N; Bingöl Özakpınar, Ö; Ercan, F; Kolgazi, M; Şener, G | 1 |
| Fu, Y; Gao, G; Hölscher, C; Li, EW; Qiao, Y; Wang, H; Wang, P; Xie, Z; Xu, J; Yuan, Y; Zhang, X; Zhang, Z | 1 |
| Dong, X; Strand-Amundsen, RJ; Sun, X; Tonnessen, TI; Yang, R; Zhu, S | 1 |
| Xiong, P; Zhu, YF | 1 |
| Cheng, F; Du, X; Li, C; Lian, Y; Ma, C; Mu, J; Song, W; Wang, G; Wang, Q; Wang, X; Wang, Z; Wei, Z; Xu, X; Yin, X; Yue, W; Zhai, C; Zhang, X; Zhu, W | 1 |
| Fukuzawa, Y; Inoue, T; Ishii, N; Ito, K; Kobayashi, Y; Nakade, Y; Nakao, H; Ohashi, T; Sakamoto, K; Sumida, Y; Umezawa, K; Yamamoto, T; Yamauchi, T; Yoneda, M | 1 |
| Amanat, S; Bagheri Lankarani, K; Eftekhari, MH; Fararouei, M; Massoumi, SJ | 1 |
| Chen, J; Ding, X; Jian, T; Li, W; Lv, H; Ma, L; Ren, B; Tong, B; Wu, Y; Zhao, L; Zuo, Y | 1 |
| Huang, YP; Jiang, CH; Sheng, XP; Wang, YT; Yin, ZQ; Zhang, J; Zhao, MG | 1 |
| Han, C; Li, J; Li, S; Liu, X; Ma, Y; Wang, X; Zhang, J; Zhang, L; Zheng, L | 1 |
| Chen, S; Li, H; Liang, H; Tang, J; Wu, C; Yang, J | 1 |
| Lee, S; Nam, KH; Ryu, DY; Seong, JK | 1 |
| Brocker, CN; Gonzalez, FJ; Kim, D; Krausz, KW; Li, G; Patel, DP; Velenosi, TJ; Yan, T; Yue, J | 1 |
| Chen, JR; Ko, J; Yang, HY; Yeh, WJ | 1 |
| Abdel Azim, SA; Ali, O; Darwish, HA; Eldeib, KM | 1 |
| Abd-Elhady, EE; Al-Siedy, ESK; Hussein, AMS; Mohamed, DA; Y Al-Okbi, S | 1 |
| Liu, CY; Liu, X; Xie, ZH; Zhang, Y | 1 |
| Chen, J; Ding, X; Jian, T; Li, J; Li, W; Lv, H; Ren, B; Yu, C; Zuo, Y | 1 |
| Agah, S; Eslami, O; Hosseini, AF; Jazayeri, S; Maleki, Z; Norouzi, H; Shidfar, F | 1 |
| Akhondi-Meybodi, M; Fallahzadeh, H; Hosseinzadeh, M; Mozaffari-Khosravi, H; Ranjbar, AM; Sangsefidi, ZS | 1 |
| Chen, HH; Chen, W; Ding, W; He, JM; Huang, L; Lu, TN; Wang, MQ; Wang, ZG; Yang, Q | 1 |
| Duan, Z; Hu, H; Hu, X; Li, G; Wang, J; Wu, J; Xie, Q; Yan, S; Yin, D | 1 |
| Haji, AA; Japar, A; Parhat, K; Qu, SS; Wei, YY; Yan, D | 1 |
| Chen, XQ; Cui, WX; Mao, Q; Wang, Q; Wei, XL; Wen, XD; Yang, J | 1 |
| Chen, X; Hu, X; Xu, C; You, S; Zhao, Q | 1 |
| Jung, JH; Kim, HS | 1 |
| Aleksić, V; Cerović, I; Jorgačević, B; Mladenović, D; Ninković, M; Prokić, V; Radosavljević, T; Stanković, M; Stanković, MN; Vučević, D; Vukićević, RJ | 1 |
| Cui, Y; Li, X; Wang, Q; Zhang, X | 1 |
| Deng, W; Gao, H; Guang, L; Li, D; Xu, L | 1 |
| Qin, S; Sang, H; Si, Y; Wang, J; Xu, X; Yang, N; Yao, S; Zhai, L; Zhang, Y; Zu, D | 1 |
| Gu, YE; Liu, XC; Yao, Z | 1 |
| Cervinková, Z; Drahota, Z; Endlicher, R; Garnol, T; Kučera, O; Lotková, H; Roušar, T | 1 |
| Tang, W; Yin, J; Zeng, L; Zhou, B | 1 |
| Carretero, A; Donato, MT; García-Cañaveras, JC; Gómez-Lechón, MJ; Lahoz, A; León, Z; Zaragoza, A | 1 |
| Chen, R; Huang, XK; Yu, H; Zeng, MH; Zeng, ZH | 1 |
| Bruno, RS; Chung, MY; Clark, RM; Lee, JY; Mah, E; Masterjohn, C; Noh, SK; Park, HJ; Park, YK | 1 |
| Ao, N; Du, J; Wang, X; Xu, J; Yang, J | 1 |
| He, M; Li, S; Niu, S; Peng, Y; Wang, L | 1 |
| Deng, W; Gao, H; Guan, L; Xu, L; Zeng, Z; Zhang, H; Zhou, X | 1 |
| Dragutinović, V; Ješić Vukićević, R; Jorgačević, B; Mladenović, D; Ninković, M; Radosavljević, T; Vatazević, A; Vesković, M; Vučević, D | 1 |
| Cui, Y; Deng, M; Qi, ZG; Shang, X; Wang, XL; Xie, ML; Xue, J; Zhang, Y; Zhao, X | 1 |
| Chen, J; Dong, L; Jin, QM; Kong, WZ; Wang, YC | 1 |
| Handa, P; Kowdley, KV; Maliken, BD; Morgan-Stevenson, V; Nelson, JE; Washington, S; Westerman, M; Yeh, MM | 1 |
| Chen, B; Chen, L; Jiang, Y; Narisi, B; Wang, H | 1 |
| Jiang, JD; Jiang, WX; Kong, WJ; Li, Z; Qu, LL; Yu, B | 1 |
| Coimbra, CC; Couto, CA; Ferrari, TC; Gioda, CR; Leite, LH; Leite, VH; Leme, FO; Lima, ML | 1 |
| Abd El-Haleim, EA; Bahgat, AK; Saleh, S | 1 |
| Han, L; Liu, J; Yu, Y; Zhu, L | 1 |
| Bao, Y; Du, J; Jia, W; Lu, J; Xiong, Q; Xu, Y; Zhang, M; Zhang, X | 1 |
| Pashkov, AN; Popov, SS; Shul'gin, KK | 1 |
| Gallegos-Corona, MA; García, OP; Madrigal-Pérez, LA; Piña-Zentella, RM; Ramos-Gomez, M; Rosado, JL | 1 |
| Ge, J; Sun, WJ; Xu, YY; Yang, J; Yu, PL; Zhang, J; Zhang, MH; Zheng, YF; Zhu, XQ | 1 |
| Cao, Y; Dou, W; Liu, Z; Ni, Z; Qin, M; Tang, H; Wang, J; Wang, X; Wen, Q; Zhang, R; Zhao, S | 1 |
| Atay, K; Canbakan, B; Dobrucalı, A; Gültepe, I; Hatemi, İ; Köroğlu, E; Şentürk, H; Sonsuz, A; Tuncer, M | 1 |
| Baston, D; Buzoianu, AD; Casoinic, F; Hancu, N; Sampelean, D | 1 |
| Cheng, M; Ren, T; Zhu, J; Zhu, L | 1 |
| Bolehovská, R; Červinková, Z; Garnol, T; Hroch, M; Kučera, O; Lotková, H; Mazurová, Y; Roušar, T; Staňková, P | 1 |
| Alloosh, M; Bell, LN; Chalasani, N; Fullenkamp, AM; Klaunig, JE; Lee, L; Mirmira, RG; Robbins, RD; Saxena, R; Sturek, M | 1 |
| Huang, C; Li, J; Ma, T; Meng, X; Tang, W; Zha, D; Zong, G | 1 |
| Abdelrahman, AM; Farghaly, E; Gomaa, W; Ibrahim, M; Kelleni, M | 1 |
| Chen, L; Chen, Z; Cheng, L; Deng, C; Jiang, W; Li, S; Ma, L; Xiang, M; Xie, C; Zheng, H | 1 |
| Bell, LN; Chalasani, N; Klipsch, A; Molleston, JP; Morton, MJ; Saxena, R; Vuppalanchi, R | 1 |
| Cervinková, Z; Haňáčková, L; Kučera, O; Lotková, H; Podhola, M; Roušar, T; Staňková, P | 1 |
| Hassanian, MA; Samy, W | 1 |
| Akin, K; Armutcu, F; Aydogan, T; Ikizek, M; Uysal, S; Yigitoglu, MR | 1 |
| Ji, G; Li, DF; Liu, P; Liu, T; Mao, ZM; Song, HY; Yang, LL; Zheng, PY | 1 |
| Ge, YL; Ji, G; Li, DF; Liu, P; Liu, T; Mao, ZM; Song, HY; Yang, LL; Zhang, L; Zhang, XQ; Zheng, PY | 1 |
| Choi, JM; Kim, BH; Kim, HC; Kim, SK; Lee, JY; Ma, JY; Oh, JM; Oh, SJ | 1 |
| Chen, M; Huang, F; Li, C; Li, K; Liang, L; Nie, H; Qin, R; Qin, W; Xiong, A; Ye, W; Yin, Z; Zhang, H; Zhang, J; Zhang, S; Zhang, X | 1 |
| Acharya, SK; Chhabra, S; Gupta, SD; Khanal, S; Kumar, R; Madan, K; Panda, SK; Prakash, S; Singla, V | 1 |
| Beauchamp, M; Klintworth, HM; Kowdley, KV; Maliken, BD; Nelson, JE; Yeh, MM | 1 |
1 review(s) available for malondialdehyde and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Soy diet for nonalcoholic fatty liver disease: A meta-analysis of randomized controlled trials.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Humans; Insulin; Lipids; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Randomized Controlled Trials as Topic; Soybean Proteins | 2021 |
8 trial(s) available for malondialdehyde and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Effects of licorice root supplementation on liver enzymes, hepatic steatosis, metabolic and oxidative stress parameters in women with nonalcoholic fatty liver disease: A randomized double-blind clinical trial.
Topics: Alanine Transaminase; Antioxidants; Dietary Supplements; Double-Blind Method; Female; Glycyrrhiza; Humans; Insulin; Lipids; Liver; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Plant Extracts; Powders | 2022 |
Danshao Shugan Granule therapy for non-alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cholesterol; Humans; Liver; Malondialdehyde; Medicine, Chinese Traditional; Mice; NF-kappa B; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Rosiglitazone; Silybin; Superoxide Dismutase; Triglycerides | 2022 |
The effect of 12 week-maximum fat oxidation intensity (FATmax) exercise on microvascular function in obese patients with nonalcoholic fatty liver disease and its mechanism.
Topics: Antioxidants; Catalase; Exercise; Female; Glutathione Peroxidase; Humans; Liver; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Superoxide Dismutase | 2023 |
The effects of zinc supplementation on metabolic profile and oxidative stress in overweight/obese patients with non-alcoholic fatty liver disease: A randomized, double-blind, placebo-controlled trial.
Topics: Humans; Insulin; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Oxidative Stress; Superoxide Dismutase; Superoxide Dismutase-1; Thiazolidinediones; Zinc | 2020 |
Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Double-Blind Method; Female; Genistein; Humans; Inflammation; Insulin; Insulin Resistance; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease | 2018 |
Effect of soy milk consumption on glycemic status, blood pressure, fibrinogen and malondialdehyde in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
Topics: Adult; Blood Glucose; Blood Pressure; Diet; Female; Fibrinogen; Humans; Insulin; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Soy Milk | 2019 |
The effect of total anthocyanin-base standardized (Cornus mas L.) fruit extract on liver function, tumor necrosis factor α, malondealdehyde, and adiponectin in patients with non-alcoholic fatty liver: a study protocol for a double-blind randomized clinica
Topics: Adiponectin; Adult; Aged; Anthocyanins; Cornus; Double-Blind Method; Female; Humans; Liver; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Plant Extracts; Research Design; Tumor Necrosis Factor-alpha | 2019 |
Paraoxonase-1 activity, malondialdehyde and glutathione peroxidase in non-alcoholic fatty liver disease and the effect of atorvastatin.
Topics: Adult; Alanine Transaminase; Anticholesteremic Agents; Aryldialkylphosphatase; Aspartate Aminotransferases; Atorvastatin; Cholesterol; Cross-Sectional Studies; Disease Progression; Fatty Liver; Female; Glutathione Peroxidase; Hepatitis; Heptanoic Acids; Humans; Lipid Peroxidation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pyrroles; Risk Factors; Triglycerides | 2011 |
84 other study(ies) available for malondialdehyde and Fatty Liver, Nonalcoholic
| Article | Year |
|---|---|
Exercise Intervention Mitigates Pathological Liver Changes in NAFLD Zebrafish by Activating SIRT1/AMPK/NRF2 Signaling.
Topics: AMP-Activated Protein Kinases; Animals; Antioxidants; Diet, High-Fat; Disease Models, Animal; Female; Interleukin-1beta; Liver; Male; Malondialdehyde; NADPH Oxidase 4; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Physical Conditioning, Animal; Reactive Oxygen Species; Signal Transduction; Sirtuin 1; Zebrafish; Zebrafish Proteins | 2021 |
Coffeeberry Activates the CaMKII/CREB/BDNF Pathway, Normalizes Autophagy and Apoptosis Signaling in Nonalcoholic Fatty Liver Rodent Model.
Topics: Animals; Apoptosis; Autophagy; Brain-Derived Neurotrophic Factor; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Caspases; Coffee; Cyclic AMP Response Element-Binding Protein; Feeding Behavior; Liver; Male; Malondialdehyde; Mice; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidation-Reduction; Protein Carbonylation; Signal Transduction; Weight Gain | 2021 |
Lycium barbarum Polysaccharides Promotes Mitochondrial Biogenesis and Energy Balance in a NAFLD Cell Model.
Topics: Adenosine Triphosphate; Alanine Transaminase; Aspartate Aminotransferases; Catalase; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Glucose; Humans; Lycium; Malondialdehyde; Mannose; Non-alcoholic Fatty Liver Disease; Nuclear Respiratory Factor 1; Organelle Biogenesis; Phospholipid Hydroperoxide Glutathione Peroxidase; Polysaccharides; PPAR gamma; RNA, Messenger; Superoxide Dismutase; Triglycerides; Uncoupling Protein 2 | 2022 |
Protective Effects of Sesamol against Liver Oxidative Stress and Inflammation in High-Fat Diet-Induced Hepatic Steatosis.
Topics: Animals; Antioxidants; Benzodioxoles; Biomarkers; Body Weight; Diet, High-Fat; Energy Intake; Inflammation; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenols; Superoxide Dismutase | 2021 |
Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cerium; Dyslipidemias; Fatty Acids, Nonesterified; Female; Fibrosis; Fructose; Humans; Liver; Liver X Receptors; Malondialdehyde; Nanoparticles; Non-alcoholic Fatty Liver Disease; Obesity; Ovariectomy; Postmenopause; Rats; Transforming Growth Factor beta1; Tumor Necrosis Factor-alpha | 2022 |
Effects of Monacolin K in Nondiabetic Patients with NAFLD: A Pilot Study.
Topics: Glutathione Disulfide; Humans; Insulin Resistance; Liver; Lovastatin; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pilot Projects; Prospective Studies | 2023 |
Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
Topics: Animals; Benzoflavones; Catalase; Cell Proliferation; Diet, High-Fat; Glycogen; Hep G2 Cells; Hepatocytes; Humans; Insulin Resistance; Lipid Droplets; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Superoxide Dismutase | 2019 |
Inactivation of the superoxide dismutase by malondialdehyde in the nonalcoholic fatty liver disease: a combined molecular docking approach to clinical studies.
Topics: Antioxidants; Humans; Malondialdehyde; Molecular Docking Simulation; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase | 2021 |
Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease.
Topics: Adipokines; Animals; Body Weight; Cerium; Cholesterol; Choline; Diet; Fatty Acids; Gene Expression Regulation; Inflammation; Lipid Metabolism; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine; Nanoparticles; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Wistar; Signal Transduction; Triglycerides | 2019 |
Codonopsis lanceolata polysaccharide CLPS alleviates high fat/high sucrose diet-induced insulin resistance via anti-oxidative stress.
Topics: Animals; Antioxidants; Blood Glucose; Catalase; China; Codonopsis; Diabetes Mellitus, Type 2; Diet, Carbohydrate Loading; Diet, High-Fat; Glucose; Glutathione; Insulin; Insulin Resistance; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phosphorylation; Plant Roots; Polysaccharides; Signal Transduction; Superoxide Dismutase | 2020 |
Effects of (-)-epicatechin on the time course of the expression of perilipins in a diet-induced model of nonalcoholic steatohepatitis.
Topics: Adiponectin; Animals; Catechin; CD36 Antigens; Cholesterol, LDL; Disease Models, Animal; Fatty Liver; Fructose; Hepatocytes; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Perilipin-2; Perilipin-3; Perilipins; Risk Factors; Triglycerides; Uncoupling Protein 2 | 2020 |
Systemic redox imbalance in patients with nonalcoholic fatty liver disease.
Topics: Adult; Antioxidants; Case-Control Studies; Female; Glutathione Peroxidase; Humans; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Obesity; Overweight; Oxidation-Reduction; Oxidative Stress; Superoxide Dismutase; Ultrasonography | 2020 |
The Effects of RKI-1447 in a Mouse Model of Nonalcoholic Fatty Liver Disease Induced by a High-Fat Diet and in HepG2 Human Hepatocellular Carcinoma Cells Treated with Oleic Acid.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carcinoma, Hepatocellular; Cholesterol; Diet, High-Fat; Disease Models, Animal; Glucose Tolerance Test; Hep G2 Cells; Humans; Insulin Resistance; Interleukin-6; Liver; Liver Neoplasms; Male; Malondialdehyde; Mice, Inbred ICR; Models, Biological; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; rhoA GTP-Binding Protein; Signal Transduction; Superoxide Dismutase; Thiazoles; Triglycerides; Tumor Necrosis Factor-alpha; Urea | 2020 |
Combined treatments with metformin and phosphodiesterase inhibitors alleviate nonalcoholic fatty liver disease in high-fat diet fed rats: a comparative study.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Body Composition; Body Weight; Cholesterol; Diet, High-Fat; Drug Synergism; Fasting; Gene Expression Regulation; Glutathione; Insulin; Liver; Male; Malondialdehyde; Metformin; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Phosphodiesterase Inhibitors; Rats; Rats, Wistar; Triglycerides; Tumor Necrosis Factor-alpha | 2020 |
Novel Combinatorial Regimen of Garcinol and Curcuminoids for Non-alcoholic Steatohepatitis (NASH) in Mice.
Topics: Actins; Animals; Antioxidants; Diarylheptanoids; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Fatty Liver; Female; Fibrosis; Glutathione; Hep G2 Cells; Hepatic Stellate Cells; Humans; Inflammation; Liver; Liver Cirrhosis; Malondialdehyde; Mice; Mice, Inbred C57BL; Muscle, Smooth; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Terpenes; Triglycerides | 2020 |
Effects of polar compounds in fried palm oil on liver lipid metabolism in C57 mice.
Topics: Animals; Cooking; Fatty Acid Synthases; Fatty Acids; Hot Temperature; Humans; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Palm Oil; PPAR alpha; Sterol Regulatory Element Binding Protein 1 | 2020 |
Effect and mechanism of ginsenoside Rg1-regulating hepatic steatosis in HepG2 cells induced by free fatty acid.
Topics: Biological Transport; Cell Survival; Fatty Acids, Nonesterified; Gene Expression Regulation; Ginsenosides; Hep G2 Cells; Humans; Malondialdehyde; Non-alcoholic Fatty Liver Disease; PPAR alpha | 2020 |
New Perspectives of S-Adenosylmethionine (SAMe) Applications to Attenuate Fatty Acid-Induced Steatosis and Oxidative Stress in Hepatic and Endothelial Cells.
Topics: Animals; Cell Line, Tumor; Cell Movement; Endothelial Cells; Hepatocytes; Malondialdehyde; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Oleanolic Acid; Oxidative Stress; Palmitic Acid; Rats; Reactive Oxygen Species; S-Adenosylmethionine | 2020 |
Morphological evaluation of the effects of exercise on high-fat-diet-induced liver damage in rats.
Topics: Animal Nutritional Physiological Phenomena; Animals; Diet, High-Fat; Disease Models, Animal; Glutathione; Lipid Metabolism; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Physical Conditioning, Animal; Rats; Rats, Sprague-Dawley | 2020 |
Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
Topics: Abietanes; Animals; Antioxidant Response Elements; Cholesterol; Ferroptosis; Glutathione; HEK293 Cells; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; Lipid Peroxidation; Male; Malondialdehyde; Membrane Proteins; Mice; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Phospholipid Hydroperoxide Glutathione Peroxidase; Reactive Oxygen Species; S100 Calcium-Binding Protein A4; Signal Transduction; Triglycerides | 2021 |
Ethyl pyruvate supplemented in drinking water ameliorates experimental nonalcoholic steatohepatitis.
Topics: Animals; Antioxidants; Bacterial Translocation; Diet; Drinking Water; Interleukin-6; Liver; Liver Function Tests; Male; Malondialdehyde; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Pyruvates; Tumor Necrosis Factor-alpha | 2021 |
Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study.
Topics: Alanine Transaminase; Animals; Cholesterol; Disease Models, Animal; Drug Compounding; Drugs, Chinese Herbal; Humans; Interleukin-6; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Stress, Psychological; Superoxide Dismutase; Triglycerides | 2017 |
Conophylline inhibits non-alcoholic steatohepatitis in mice.
Topics: Alanine Transaminase; Animals; Fatty Acids, Nonesterified; Fatty Liver; Immunohistochemistry; Inflammation; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice; Non-alcoholic Fatty Liver Disease; Real-Time Polymerase Chain Reaction; RNA; Triglycerides; Vinca Alkaloids | 2017 |
A novel sesquiterpene glycoside from Loquat leaf alleviates oleic acid-induced steatosis and oxidative stress in HepG2 cells.
Topics: Cholesterol; Cytochrome P-450 CYP2E1; Dose-Response Relationship, Drug; Down-Regulation; Eriobotrya; Fatty Acids, Nonesterified; Glycosides; Hep G2 Cells; Humans; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oleic Acid; Oxidative Stress; Plant Extracts; Plant Leaves; Sesquiterpenes; Superoxide Dismutase; Triglycerides | 2018 |
Triterpenic acids-enriched fraction from Cyclocarya paliurus attenuates non-alcoholic fatty liver disease via improving oxidative stress and mitochondrial dysfunction.
Topics: Animals; Antioxidants; Cell Line, Tumor; Electron Transport Complex IV; Glutathione; Glutathione Disulfide; Heme Oxygenase-1; Hep G2 Cells; Humans; Juglandaceae; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Mitochondria; Mitochondrial Diseases; NAD(P)H Dehydrogenase (Quinone); NADH Dehydrogenase; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase; Triterpenes | 2018 |
Exenatide ameliorates hepatic steatosis and attenuates fat mass and FTO gene expression through PI3K signaling pathway in nonalcoholic fatty liver disease.
Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Blood Glucose; Body Weight; Chromones; Diet, High-Fat; Disease Models, Animal; Eating; Enzyme Inhibitors; Exenatide; Fatty Liver; Gene Expression Regulation; In Vitro Techniques; Insulin; Male; Malondialdehyde; Morpholines; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Peptides; Phosphatidylinositol 3-Kinases; Protective Agents; Rabbits; Superoxide Dismutase; Venoms | 2018 |
Optimization of dosage ratio of chlorogenic acid and gardenia glycosides in the treatment of rats with fatty liver disease induced by\
high-fat feed.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Chlorogenic Acid; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Gardenia; Glycosides; Humans; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Superoxide Dismutase; Triglycerides | 2016 |
Molybdate Attenuates Lipid Accumulation in the Livers of Mice Fed a Diet Deficient in Methionine and Choline.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Choline Deficiency; Diet; Lipid Metabolism; Liver; Male; Malondialdehyde; Methionine; Mice, Inbred C57BL; Molybdenum; Non-alcoholic Fatty Liver Disease | 2018 |
Extrahepatic PPARα modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice.
Topics: Animals; Fasting; Gas Chromatography-Mass Spectrometry; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; PPAR alpha | 2018 |
Camellia oleifera seed extract attenuated abdominal and hepatic fat accumulation in rats fed a high-fat diet.
Topics: Alanine Transaminase; Animals; Body Weight; Camellia; Diet, High-Fat; Hydroxyproline; Intra-Abdominal Fat; Leptin; Liver; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Plant Extracts; Rats; Rats, Wistar; Seeds; Taiwan; Triglycerides; Tumor Necrosis Factor-alpha | 2019 |
miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease.
Topics: Apoptosis; Autophagy; Cholesterol; Endoplasmic Reticulum Stress; Fatty Acids; Gene Expression Regulation; Hep G2 Cells; Humans; Lipid Metabolism; Malondialdehyde; MicroRNAs; Models, Biological; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Kinase C-delta; RNA, Messenger; Sterols; Triglycerides | 2018 |
Comparative Study of Orange and its Main Bioactive Constituents as Remedy for Non-alcoholic Fatty Liver in Rats.
Topics: Animals; Cholesterol; Citrus sinensis; Disease Models, Animal; Fatty Acids; Functional Food; Inflammation; Insulin Resistance; Lipids; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytochemicals; Rats; Rats, Sprague-Dawley | 2018 |
Effect of Chinese Herbal Monomer Hairy Calycosin on Nonalcoholic Fatty Liver Rats and its Mechanism.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Astragalus propinquus; Cytochrome P-450 CYP2E1; Disease Models, Animal; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Hepatocytes; Interleukin-6; Isoflavones; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2019 |
Hepatoprotective Effect of Seed Coat ofEuryale ferox Extract in Non-alcoholic Fatty Liver Disease Induced by High-fat Diet in Mice by Increasing IRs-1 and Inhibiting CYP2E1.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Diet, High-Fat; Disease Models, Animal; Enzyme Inhibitors; Insulin Receptor Substrate Proteins; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice, Inbred ICR; Non-alcoholic Fatty Liver Disease; Nymphaeaceae; Oxidative Stress; Phytotherapy; Plant Extracts; Polyphenols; Seeds; Stimulation, Chemical; Superoxide Dismutase | 2019 |
Tanshinone IIA ameliorates non-alcoholic fatty liver disease through targeting peroxisome proliferator-activated receptor gamma and toll-like receptor 4.
Topics: Abietanes; Animals; Body Weight; Lipids; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidation-Reduction; PPAR gamma; Rats, Sprague-Dawley; RNA, Messenger; Toll-Like Receptor 4 | 2019 |
Proteomic profile of carbonylated proteins in rat liver: exercise attenuated oxidative stress may be involved in fatty liver improvement.
Topics: Acyl-CoA Dehydrogenase; Animals; Biomarkers; Exercise Therapy; Fatty Liver; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Oxidative Stress; Physical Conditioning, Animal; Protein Carbonylation; Protein Interaction Maps; Proteomics; Rats; Rats, Sprague-Dawley; Triglycerides | 2013 |
[Effects of pomegranate flowers polyphenols on liver PON expression of diabetes combining non-alcoholic fat liver diseases rats].
Topics: Alanine Transaminase; Animals; Aryldialkylphosphatase; Aspartate Aminotransferases; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Liver; Flowers; Insulin; Liver; Lythraceae; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Plants, Medicinal; Polyphenols; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase | 2013 |
Triterpenoid-rich fraction from Ilex hainanensis Merr. attenuates non-alcoholic fatty liver disease induced by high fat diet in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Diet, High-Fat; Fatty Liver; Hyperlipidemias; Ilex; Inflammation; Insulin Resistance; Interleukin-6; Lipids; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytotherapy; Plant Extracts; PPAR alpha; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Triterpenes; Tumor Necrosis Factor-alpha | 2013 |
Oat β-glucan inhibits lipopolysaccharide-induced nonalcoholic steatohepatitis in mice.
Topics: Animals; Avena; beta-Glucans; Disease Models, Animal; Dose-Response Relationship, Drug; Endotoxemia; Fatty Liver; Glucagon-Like Peptide 2; Glucose Intolerance; Inflammation; Insulin Resistance; Interleukin-1beta; Interleukin-6; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Transaminases; Triglycerides; Tumor Necrosis Factor-alpha; Weight Gain | 2013 |
The inhibitory effect of black soybean on hepatic cholesterol accumulation in high cholesterol and high fat diet-induced non-alcoholic fatty liver disease.
Topics: Adiponectin; AMP-Activated Protein Kinases; Animals; ATP Binding Cassette Transporter 1; Bile Acids and Salts; Blood Glucose; Catalase; Cholesterol; Diet, High-Fat; Equol; Fatty Liver; Glycine max; Hydroxymethylglutaryl CoA Reductases; Isoflavones; Lipid Metabolism; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR gamma; RNA, Messenger; Signal Transduction; Sterol Regulatory Element Binding Protein 2; Superoxide Dismutase; Transcriptome; Triglycerides | 2013 |
Dynamics of oxidative/nitrosative stress in mice with methionine-choline-deficient diet-induced nonalcoholic fatty liver disease.
Topics: Animals; Antioxidants; C-Reactive Protein; Catalase; Choline Deficiency; Disease Models, Animal; Ferritins; Glutathione; Lipid Peroxidation; Liver; Male; Malondialdehyde; Methionine; Mice, Inbred C57BL; Nitrates; Nitrites; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Superoxide Dismutase; Time Factors | 2014 |
Experimental nonalcoholic fatty liver disease in mice leads to cytochrome p450 2a5 upregulation through nuclear factor erythroid 2-like 2 translocation.
Topics: Animals; Aryl Hydrocarbon Hydroxylases; Cell Nucleus; Cytochrome P450 Family 2; Cytoplasm; Diet, High-Fat; Glutathione; Liver; Male; Malondialdehyde; Mice; Mice, Inbred ICR; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2013 |
[Effects of glucagon-like peptide-1 on liver oxidative stress, TNF-α and TGF-β1 in rats with non-alcoholic fatty liver disease].
Topics: Alanine Transaminase; Animals; Cholesterol; Fatty Acids, Nonesterified; Hypoglycemic Agents; Liraglutide; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha | 2013 |
Celastrus orbiculatus Thunb. ameliorates high-fat diet-induced non-alcoholic fatty liver disease in guinea pigs.
Topics: Animals; Body Weight; Celastrus; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Fatty Liver; Guinea Pigs; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Metabolism; Liver; Liver Function Tests; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Organ Size; Real-Time Polymerase Chain Reaction; Simvastatin; Superoxide Dismutase | 2013 |
Schisandra chinensis Baill, a Chinese medicinal herb, alleviates high-fat-diet-inducing non-alcoholic steatohepatitis in rats.
Topics: Animals; Cholesterol; Cholesterol, LDL; Diet, High-Fat; Dietary Fats; Drugs, Chinese Herbal; Fatty Liver; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Phytotherapy; Random Allocation; Rats; Rats, Wistar; Rosiglitazone; Schisandra; Superoxide Dismutase; Thiazolidinediones | 2014 |
The effect of tert-butyl hydroperoxide-induced oxidative stress on lean and steatotic rat hepatocytes in vitro.
Topics: Animals; Cells, Cultured; Diet, High-Fat; Glutathione; Hepatocytes; L-Lactate Dehydrogenase; Lipid Peroxidation; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; tert-Butylhydroperoxide | 2014 |
[Establishment of a L-02 cell model of hepatic steatosis].
Topics: Apoptosis; Cell Line; Drugs, Chinese Herbal; Fatty Acids, Nonesterified; Fatty Liver; Humans; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Triglycerides | 2014 |
In vitro/in vivo screening of oxidative homeostasis and damage to DNA, protein, and lipids using UPLC/MS-MS.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; DNA Damage; Glutathione Transferase; Hepatocytes; Homeostasis; Humans; Lipids; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Oxygen; Perfusion; Proteins; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tandem Mass Spectrometry | 2014 |
[Effect of electroacupuncture stimulation of back-shu points on expression of TNF-alpha and lipid peroxidation reaction in the liver tissue in non-alcoholic fatty liver disease rats].
Topics: Acupuncture Points; Animals; Electroacupuncture; Fatty Liver; Humans; Lipid Peroxidation; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2014 |
Green Tea Lowers Hepatic COX-2 and Prostaglandin E2 in Rats with Dietary Fat-Induced Nonalcoholic Steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Camellia sinensis; Cyclooxygenase 2; Diet, High-Fat; Dietary Fats; Dinoprostone; Fatty Acids; Hypolipidemic Agents; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Obesity; Phytotherapy; Plant Extracts; Rats, Wistar; Tea | 2015 |
[Influence of GLP-1 on oxidative stress injury in non-alcoholic fatty liver disease rats].
Topics: Animals; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Glucagon-Like Peptide 1; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Triglycerides | 2014 |
Exendin-4 regulates redox homeostasis in rats fed with high-fat diet.
Topics: Animals; Cystathionine beta-Synthase; Diet, High-Fat; Down-Regulation; Exenatide; Glutathione; Homeostasis; Homocysteine; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Peptides; Rats; Rats, Sprague-Dawley; RNA, Messenger; Venoms | 2015 |
The Glucagon-Like Peptide-1 Analogue Liraglutide Inhibits Oxidative Stress and Inflammatory Response in the Liver of Rats with Diet-Induced Non-alcoholic Fatty Liver Disease.
Topics: Adiponectin; Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Diet, High-Fat; Fatty Acids, Nonesterified; Glucagon-Like Peptide 1; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Liraglutide; Liver; Male; Malondialdehyde; Mitogen-Activated Protein Kinase 8; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2015 |
Rimonabant Improves Oxidative/Nitrosative Stress in Mice with Nonalcoholic Fatty Liver Disease.
Topics: Animals; Cannabinoid Receptor Antagonists; Diet, High-Fat; Disease Models, Animal; Glutathione; Liver; Male; Malondialdehyde; Metals; Mice; Mice, Inbred C57BL; Nitrates; Nitrites; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Piperidines; Pyrazoles; Rimonabant; Superoxide Dismutase | 2015 |
PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Topics: Anilides; Animals; Chemokine CCL2; Cytokines; Disease Models, Animal; Fatty Acids, Nonesterified; Fenofibrate; Gene Expression Regulation; Glutathione; Indoles; Inflammation; Interleukin-6; Interleukin-8; Lipid Metabolism; Liver; Male; Malondialdehyde; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; PPAR alpha; PPAR gamma; Rats; Rats, Sprague-Dawley; Rosiglitazone; Superoxide Dismutase; Thiazolidinediones; Tumor Necrosis Factor-alpha | 2015 |
Effects of salvianolic acid B on liver mitochondria of rats with nonalcoholic steatohepatitis.
Topics: Animals; Apoptosis; Benzofurans; Biomarkers; Caspase 3; Cytochromes c; Diet, High-Fat; Disease Models, Animal; GTP Phosphohydrolases; Lipid Peroxidation; Liver; Male; Malondialdehyde; Membrane Potential, Mitochondrial; Membrane Proteins; Mitochondria, Liver; Mitochondrial Proteins; Mitochondrial Swelling; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats, Sprague-Dawley; Superoxide Dismutase | 2015 |
Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice.
Topics: Adaptive Immunity; Animals; Disease Models, Animal; Immunity, Innate; Iron Overload; Liver; Malondialdehyde; Mice; Mice, Obese; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Reactive Oxygen Species; Receptors, Leptin | 2016 |
Li-Gan-Shi-Liu-Ba-Wei-San improves non-alcoholic fatty liver disease through enhancing lipid oxidation and alleviating oxidation stress.
Topics: Animals; Drugs, Chinese Herbal; Hep G2 Cells; Humans; I-kappa B Proteins; Lipid Metabolism; Liver; Malondialdehyde; NF-KappaB Inhibitor alpha; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Oxidation-Reduction; Oxidative Stress; PPAR alpha; PPAR-beta; Rats, Sprague-Dawley; Superoxide Dismutase | 2015 |
Gastrodin Ameliorates Oxidative Stress and Proinflammatory Response in Nonalcoholic Fatty Liver Disease through the AMPK/Nrf2 Pathway.
Topics: AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; Benzyl Alcohols; Gastrodia; Glucosides; Heme Oxygenase-1; Hep G2 Cells; Humans; Inflammation; Male; Malondialdehyde; Mice, Inbred C57BL; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phytotherapy; Plant Extracts; Rats, Sprague-Dawley; Reactive Oxygen Species; Superoxide Dismutase; Triglycerides | 2016 |
A Novel Wistar Rat Model of Obesity-Related Nonalcoholic Fatty Liver Disease Induced by Sucrose-Rich Diet.
Topics: Animals; Biomarkers; Blood Glucose; Body Mass Index; Catalase; Dietary Sucrose; Disease Models, Animal; Exercise Therapy; Insulin; Insulin Resistance; Leptin; Lipids; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Rats, Wistar; Running; Superoxide Dismutase; Time Factors | 2016 |
Effects of combined PPAR-γ and PPAR-α agonist therapy on fructose induced NASH in rats: Modulation of gene expression.
Topics: Adiponectin; Adipose Tissue; Animals; Blood Glucose; Body Weight; Dose-Response Relationship, Drug; Drug Interactions; Fenofibrate; Fructose; Gene Expression Regulation; Glutathione; Homeostasis; Insulin; Leptin; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Pioglitazone; PPAR alpha; PPAR gamma; Rats; Rats, Wistar; Thiazolidinediones; Triglycerides; Tumor Necrosis Factor-alpha | 2016 |
Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
Topics: Alanine Transaminase; Animals; Diet, High-Fat; Fatty Acids, Nonesterified; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Random Allocation; Rats; Rats, Wistar; Triglycerides | 2016 |
Osteocalcin improves nonalcoholic fatty liver disease in mice through activation of Nrf2 and inhibition of JNK.
Topics: Animals; Catalase; Diet, High-Fat; Disease Models, Animal; Glucose; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; MAP Kinase Signaling System; Mice; NF-E2-Related Factor 2; Non-alcoholic Fatty Liver Disease; Osteocalcin; Oxidation-Reduction; Oxidative Stress; Signal Transduction; Triglycerides | 2016 |
[EFFECTS OF MELATONIN ON THE ACONITATE HYDRATASE ACTIVITY, CONTENT OF LIPID PEROXIDATION PRODUCTS AND SOME NON-ENZYMATIC ANTIOXIDANTS IN THE BLOOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS COMPLICATED BY STEATOHEPATITIS].
Topics: Aconitate Hydratase; Adult; Aged; alpha-Tocopherol; Antioxidants; Citric Acid; Diabetes Mellitus, Type 2; Female; Humans; Lipid Peroxidation; Liver; Male; Malondialdehyde; Melatonin; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress | 2015 |
Lycopene Improves Diet-Mediated Recuperation in Rat Model of Nonalcoholic Fatty Liver Disease.
Topics: Animals; Carotenoids; Cholesterol; Diet, High-Fat; Glutathione Peroxidase; Humans; Liver; Lycopene; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Triglycerides | 2016 |
Intravenous Administration of Multiwalled Carbon Nanotubes Aggravates High-Fat Diet-Induced Nonalcoholic Steatohepatitis in Sprague Dawley Rats.
Topics: Animals; Aspartate Aminotransferases; Diet, High-Fat; Fatty Acids, Nonesterified; gamma-Glutamyltransferase; Glutathione; Glutathione Peroxidase; Injections, Intravenous; Liver; Male; Malondialdehyde; Nanotubes, Carbon; Non-alcoholic Fatty Liver Disease; Rats, Sprague-Dawley; Superoxide Dismutase; Triglycerides | 2016 |
Deletion of Nrf2 leads to hepatic insulin resistance via the activation of NF-κB in mice fed a high-fat diet.
Topics: Animals; Blood Glucose; Diet, High-Fat; Disease Models, Animal; Gene Deletion; Glutathione; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; Mice; Mice, Knockout; NF-E2-Related Factor 2; NF-kappa B; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Signal Transduction | 2016 |
Role of oxidative stress and insulin resistance in disease severity of non-alcoholic fatty liver disease.
Topics: Adult; Ascorbic Acid; Female; Glutathione; Humans; Insulin; Insulin Resistance; Liver; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Severity of Illness Index; Superoxide Dismutase; Vitamin E | 2016 |
Serum Levels of Oxidative Stress Markers in Patients with Type 2 Diabetes Mellitus and Non-alcoholic Steatohepatitis.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Case-Control Studies; Diabetes Mellitus, Type 2; Dinoprost; Female; Humans; Male; Malondialdehyde; Middle Aged; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Protein Carbonylation; Risk Factors | 2016 |
The Combination of Blueberry Juice and Probiotics Ameliorate Non-Alcoholic Steatohepatitis (NASH) by Affecting SREBP-1c/PNPLA-3 Pathway via PPAR-α.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Bifidobacterium animalis; Blueberry Plants; Caspase 3; Cholesterol; Disease Models, Animal; Fruit; Fruit and Vegetable Juices; Hep G2 Cells; Hepatocytes; Humans; Interleukin-6; Lactobacillus delbrueckii; Lipid Metabolism; Male; Malondialdehyde; Membrane Proteins; Non-alcoholic Fatty Liver Disease; Phospholipases A2; PPAR alpha; Probiotics; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Streptococcus thermophilus; Triglycerides; Tumor Necrosis Factor-alpha | 2017 |
The effect of rat strain, diet composition and feeding period on the development of a nutritional model of non-alcoholic fatty liver disease in rats.
Topics: Animals; Diet; Dietary Fats; Disease Models, Animal; Fatty Liver; Glutathione; Ion Channels; Liver; Male; Malondialdehyde; Mitochondrial Proteins; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Rats, Wistar; Triglycerides; Uncoupling Protein 2 | 2011 |
Effect of different obesogenic diets on pancreatic histology in Ossabaw miniature swine.
Topics: Adipose Tissue; Animals; Diet; Diet, Atherogenic; Disease Models, Animal; Energy Intake; Fatty Liver; Fructose; Malondialdehyde; Metabolic Syndrome; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Pancreas; Swine; Swine, Miniature | 2011 |
Hepatoprotective effects of geniposide in a rat model of nonalcoholic steatohepatitis.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Aspartate Aminotransferases; Cytochrome P-450 CYP2E1; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fatty Liver; Insulin; Iridoids; Lipid Metabolism; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; PPAR alpha; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2011 |
Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease.
Topics: Alanine Transaminase; Animals; Aspirin; Cyclooxygenase 2; Fatty Liver; Gene Expression Regulation, Enzymologic; Liver; Male; Malondialdehyde; Nitric Oxide; Nitric Oxide Synthase Type II; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Triglycerides | 2011 |
A novel agonist of PPAR-γ based on barbituric acid alleviates the development of non-alcoholic fatty liver disease by regulating adipocytokine expression and preventing insulin resistance.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; AMP-Activated Protein Kinases; Animals; Barbiturates; Carnitine O-Palmitoyltransferase; Cell Differentiation; Down-Regulation; Fatty Liver; Gene Expression Regulation; Gene Expression Regulation, Enzymologic; Glucose; Hep G2 Cells; Humans; Insulin Resistance; Liver; Male; Malondialdehyde; Mice; Non-alcoholic Fatty Liver Disease; PPAR gamma; Rats; Rats, Wistar; Triglycerides; Up-Regulation | 2011 |
Hepatic lipid peroxidation and cytochrome P-450 2E1 in pediatric nonalcoholic fatty liver disease and its subtypes.
Topics: Adolescent; Biopsy; Body Mass Index; Case-Control Studies; Child; Child, Preschool; Cytochrome P-450 CYP2E1; Fatty Liver; Female; Humans; Infant; Lipid Peroxidation; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Retrospective Studies | 2011 |
Susceptibility of rat non-alcoholic fatty liver to the acute toxic effect of acetaminophen.
Topics: Acetaminophen; Animals; Biomarkers; Caspase 3; Chemical and Drug Induced Liver Injury; Cholesterol; Disease Models, Animal; Disease Susceptibility; Electron Transport Chain Complex Proteins; Fatty Liver; Glutathione; Glutathione Disulfide; Liver; Male; Malondialdehyde; Necrosis; Non-alcoholic Fatty Liver Disease; Rats; Rats, Sprague-Dawley; Risk Factors; Severity of Illness Index; Time Factors; Transforming Growth Factor beta1; Triglycerides; Tumor Necrosis Factor-alpha | 2012 |
Some inflammatory cytokine levels, iron metabolism and oxidan stress markers in subjects with nonalcoholic steatohepatitis.
Topics: Adult; Alanine Transaminase; Antimicrobial Cationic Peptides; Biomarkers; Case-Control Studies; Cytokines; Fatty Liver; Female; Ferritins; Hepcidins; Humans; Inflammation Mediators; Iron; Liver; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Ultrasonography | 2011 |
[Effects of the mixture of Swertia pseudochinensis Hara and Silybum marianum Gaertn extracts on CCl(4)-induced liver injury in rats with non-alcoholic fatty liver disease].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Diet, High-Fat; Drugs, Chinese Herbal; Fatty Liver; Glutathione; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar; Silybum marianum; Swertia; Triglycerides | 2012 |
Dangfei liganning capsules attenuate the susceptibility of rat nonalcoholic fatty liver to carbon tetrachloride toxicity.
Topics: Animals; Capsules; Carbon Tetrachloride; Caspase 3; Cytochrome P-450 CYP2E1; Drugs, Chinese Herbal; Fatty Liver; Glutathione; Humans; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Rats; Rats, Wistar | 2011 |
Effects of palmitic acid on TNF-α-induced cytotoxicity in SK-Hep-1 cells.
Topics: Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Fatty Acids; Fatty Liver; Glutathione; Humans; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2012 |
Protective effects of gypenosides against fatty liver disease induced by high fat and cholesterol diet and alcohol in rats.
Topics: Alanine Transaminase; Animals; Apoptosis; Aspartate Aminotransferases; Biomarkers; Cholesterol, Dietary; Cholesterol, LDL; Cytoprotection; Diet, High-Fat; Disease Models, Animal; Fatty Acids, Nonesterified; Fatty Liver; Fatty Liver, Alcoholic; Gynostemma; Liver; Male; Malondialdehyde; Mitochondria, Liver; Non-alcoholic Fatty Liver Disease; Plant Extracts; Plant Preparations; PPAR alpha; Protective Agents; Rats; Rats, Sprague-Dawley; RNA, Messenger; Superoxide Dismutase; Triglycerides | 2012 |
Association of pro-inflammatory cytokines, adipokines & oxidative stress with insulin resistance & non-alcoholic fatty liver disease.
Topics: Adipokines; Adult; Ascorbic Acid; Cytokines; Fatty Liver; Female; Hepatitis B, Chronic; Humans; India; Inflammation; Insulin; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; Non-alcoholic Fatty Liver Disease; Obesity; Oxidative Stress; Statistics as Topic; Superoxide Dismutase | 2012 |
Hepatic reticuloendothelial system cell iron deposition is associated with increased apoptosis in nonalcoholic fatty liver disease.
Topics: Adult; Apoptosis; Biomarkers; Fatty Liver; Female; Hepatocytes; Humans; Iron; Keratin-18; Liver; Male; Malondialdehyde; Middle Aged; Mononuclear Phagocyte System; Necrosis; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Registries; Retrospective Studies; Thioredoxins | 2013 |